Andere Kunden interessierten sich auch für
![Computational Approaches for The Prediction of antidiabetic analogues]( "Computational Approaches for The Prediction of antidiabetic analogues")
Computational Approaches for The Prediction of antidiabetic analogues36,99 €![Antimicrobial Activity of 1,3,4-oxadiazole analogues]( "Antimicrobial Activity of 1,3,4-oxadiazole analogues")
Antimicrobial Activity of 1,3,4-oxadiazole analogues51,99 €![Design, synthesis and anti-HIV activity of curcumin analogues]( "Design, synthesis and anti-HIV activity of curcumin analogues")
Design, synthesis and anti-HIV activity of curcumin analogues26,99 €![Synthesis & Biological Evaluation Of 1,3,4 Oxadiazole Derivatives]( "Synthesis & Biological Evaluation Of 1,3,4 Oxadiazole Derivatives")
Synthesis & Biological Evaluation Of 1,3,4 Oxadiazole Derivatives23,99 €![ANTI-BACTERIAL ACTIVITY OF THIOL-SUBSTITUTED 1,3,4- OXADIAZOLES]( "ANTI-BACTERIAL ACTIVITY OF THIOL-SUBSTITUTED 1,3,4- OXADIAZOLES")
ANTI-BACTERIAL ACTIVITY OF THIOL-SUBSTITUTED 1,3,4- OXADIAZOLES29,99 €![Synthesis of Curcumin Analogues as Novel Anti Malarial Agents]( "Synthesis of Curcumin Analogues as Novel Anti Malarial Agents")
Synthesis of Curcumin Analogues as Novel Anti Malarial Agents26,99 €![Rational Drug Design of Substituted Analogues Angiotensin II Receptor]( "Rational Drug Design of Substituted Analogues Angiotensin II Receptor")
Rational Drug Design of Substituted Analogues Angiotensin II Receptor36,99 €
A series of 11 oxadiazole analogues were subjected to molecular properties prediction and drug likeness by Molinspiration and MolSoft software, lipophilicity and solubility parameters using ALOGPS 2.1 program. The compounds followed the Lipinski "Rule of five" were synthesized for antimicrobial screening as oral bioavailable drugs/leads. Further the structure of the synthesized compounds was confirmed by spectral analyses (IR, NMR and mass) and the compounds (4a-k) were evaluated for antibacterial and antifungal activities as per the standard protocol. N-(2-Methylphenyl)-5-(4-chlorophenyl)-1,3,4-oxadiazol-2-amine, 4c was found to have maximum antibacterial activity while N-(2-methylphenyl)-5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-amine, 4d showed maximum antifungal activity.